CN103483276A - 一种凡德他尼杂质的制备方法 - Google Patents
一种凡德他尼杂质的制备方法 Download PDFInfo
- Publication number
- CN103483276A CN103483276A CN201310428221.4A CN201310428221A CN103483276A CN 103483276 A CN103483276 A CN 103483276A CN 201310428221 A CN201310428221 A CN 201310428221A CN 103483276 A CN103483276 A CN 103483276A
- Authority
- CN
- China
- Prior art keywords
- formula
- impurity
- preparation
- acid
- vandetanib
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
- C07D239/72—Quinazolines; Hydrogenated quinazolines
- C07D239/86—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
- C07D239/94—Nitrogen atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
Claims (6)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310428221.4A CN103483276B (zh) | 2013-09-22 | 2013-09-22 | 一种凡德他尼杂质的制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310428221.4A CN103483276B (zh) | 2013-09-22 | 2013-09-22 | 一种凡德他尼杂质的制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103483276A true CN103483276A (zh) | 2014-01-01 |
CN103483276B CN103483276B (zh) | 2018-04-17 |
Family
ID=49823925
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201310428221.4A Active CN103483276B (zh) | 2013-09-22 | 2013-09-22 | 一种凡德他尼杂质的制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103483276B (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2015175750A1 (en) * | 2014-05-15 | 2015-11-19 | The Methodist Hospital System | Multivalent ligands targeting vegfr |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0566226A1 (en) * | 1992-01-20 | 1993-10-20 | Zeneca Limited | Quinazoline derivatives |
CN101219145A (zh) * | 1999-11-05 | 2008-07-16 | 阿斯特拉曾尼卡有限公司 | 作为vegf抑制剂的喹唑啉衍生物 |
-
2013
- 2013-09-22 CN CN201310428221.4A patent/CN103483276B/zh active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0566226A1 (en) * | 1992-01-20 | 1993-10-20 | Zeneca Limited | Quinazoline derivatives |
CN101219145A (zh) * | 1999-11-05 | 2008-07-16 | 阿斯特拉曾尼卡有限公司 | 作为vegf抑制剂的喹唑啉衍生物 |
Non-Patent Citations (2)
Title |
---|
STEFANO DALL’ACQUA,等: "Isolation and structure elucidation of the main UV-A photoproducts of vandetanib", 《JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS》 * |
赵兴旺: "凡德他尼", 《中国药物化学杂志》 * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2015175750A1 (en) * | 2014-05-15 | 2015-11-19 | The Methodist Hospital System | Multivalent ligands targeting vegfr |
US10011587B2 (en) | 2014-05-15 | 2018-07-03 | The Methodist Hospital System | Multivalent ligands targeting VEGFR |
Also Published As
Publication number | Publication date |
---|---|
CN103483276B (zh) | 2018-04-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2015188686A1 (zh) | 塞瑞替尼及其中间体的制备方法 | |
TW201516042A (zh) | 組織胺h受體之苯并咪唑-2-基嘧啶調控劑 | |
CN104829602A (zh) | 一种依匹哌唑的制备方法 | |
CN103965114A (zh) | 氘代的苯基氨基嘧啶化合物以及包含该化合物的药物组合物 | |
CN101891676A (zh) | 一种新的5-甲基-1-苯基-2-(1h)-吡啶酮的制备方法 | |
CA2971093A1 (en) | Process of making cenicriviroc and related analogs | |
CN103254201B (zh) | 一种阿塞那平的制备方法 | |
CN105294534A (zh) | 制备阿普司特及其中间体的产业化方法 | |
CN104592195A (zh) | 一种苯甲酸阿格列汀的制备方法 | |
CN103755648B (zh) | 一种吉非替尼的新杂质及其制备方法 | |
CN104031029A (zh) | 单一光学异构体的2-[(4-氯苯基)(哌啶-4-氧基)甲基]吡啶的合成方法 | |
CN103360326A (zh) | 吉非替尼晶型i的精制方法 | |
CN103483276A (zh) | 一种凡德他尼杂质的制备方法 | |
CN103980249B (zh) | 一种苯甲酸阿格列汀的精制方法 | |
CN103787924A (zh) | 抗肿瘤药物Belinostat的一种新纯化方法 | |
WO2021111462A1 (en) | An improved process for the preparation of osimertinib mesylate | |
CN102267983B (zh) | 一种含均四嗪环的均三嗪衍生化合物及其制备方法 | |
CN102850282A (zh) | 3-烷氧基取代-2-吡嗪甲酰氨类化合物及其用途 | |
CN107936045B (zh) | 一种高纯度氟比洛芬已知杂质的制备方法 | |
CN107001284B (zh) | 一种雄性激素受体抑制剂的结晶形式及其制备方法 | |
CN107987080A (zh) | 一种利拉利汀晶型a的制备方法 | |
CN113980012A (zh) | 恩曲他滨的纯化方法 | |
CN104211693A (zh) | 一种利伐沙班新晶型及其制备方法与用途 | |
CN108250140A (zh) | 一种马来酸茚达特罗的制备方法 | |
CN106854182B (zh) | 一种2,5-二氯-n-(2-(异丙基磺酰基)苯基)嘧啶-4-胺的制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
CB02 | Change of applicant information |
Address after: Qixia District of Nanjing City, Jiangsu province 210033 Xianlin streets latitude road No. 9, building F6, room 317 Applicant after: Nanjing H&D Pharmaceutical Technology Co.,Ltd. Address before: 210038 No. 422, Yan Lu, Nanjing, Jiangsu Applicant before: Nanjing H&D Pharmaceutical Technology Co.,Ltd. |
|
COR | Change of bibliographic data | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
CP01 | Change in the name or title of a patent holder | ||
CP01 | Change in the name or title of a patent holder |
Address after: 210033 room 317, building F6, No.9, Weidi Road, Xianlin street, Qixia District, Nanjing City, Jiangsu Province Patentee after: Nanjing H&D Pharmaceutical Technology Co.,Ltd. Address before: 210033 room 317, building F6, No.9, Weidi Road, Xianlin street, Qixia District, Nanjing City, Jiangsu Province Patentee before: Nanjing H&D Pharmaceutical Technology Co.,Ltd. |
|
CP02 | Change in the address of a patent holder | ||
CP02 | Change in the address of a patent holder |
Address after: Building D3, No. 9, Weidi Road, Xianlin Street, Qixia District, Nanjing, Jiangsu 210033 Patentee after: Nanjing H&D Pharmaceutical Technology Co.,Ltd. Address before: 210033 room 317, building F6, No.9, Weidi Road, Xianlin street, Qixia District, Nanjing City, Jiangsu Province Patentee before: Nanjing H&D Pharmaceutical Technology Co.,Ltd. |